Skip to main content

Table 1 Summary of clinical trials on DS

From: Mechanism-based biomarkers for the quality control of Dangkwisoo-san: a scoping review

Target disease

Study design (sample size, n)

Intervention

Control

Effects of Dangkwisoo-san

References

Intervention

Type of preparation form

Extraction method

 

Duration (frequency)

Outcomes

Results

Pulmonary contusion

RCT (80:I 40, C 40)

DS + Usual carea

Decoction

NA

Total 5600 ml

(400 ml/day)

2 weeks (2/day)

Usual carea

1) Changes in serum TNF-a, IL-6, and CRP levels (1, 3, 7, and 12 days)

2) Incidence of SIRS and ARDS

3) Mortality

4) Average hospital stay

1) p < 0.01

2) I: SIRS (n = 6), ARDS (n = 2); C: SIRS (n = 11), ARDS (n = 5)

3) None (all groups)

4) p < 0.05

Wei, C. H

[31]

Acute lateral ankle sprain

RCT (48:I 24, C 24)

DS + Acupuncture

Powder capsule

Water

Total 37.8 g

(9-capsule/day)

7 days (3/day)

Placebo capsule + Acupuncture

1) VAS

2) FAOS

3) Edema

4) EQ-5D-5L

5) Number of recurrent ankle sprains

1–4) p < 0.01

5) NS

Kim, J. H

[27]

Ankle sprain

RCT (45:I 22, C 23)

DS + Acupuncture

Powder capsule

Water

Total 37.8 g

(9-capsule/day)

7 days (3/day)

Acupuncture

1) FAOS

2) EQ-5D-5L

3) ICER

4) Costs

5) PSA

1, 2, 4, 5) NS

3) -151348 (Korean Won/QALY)

Huang, S. Z

[35]

Bruise

Case report (1)

DS

NA

NA

NA

10 days (NA)

NA

1) Headache, lower back pain

2) Expiratory dyspnea

3) Groan

4) Tears

5) Food taste

6) Epigastric lumpy stiffness

7) Pressing pain

8) Heart bottom gore

1–4, 7, 8) Disappear

5) Good

6) Soften

NA [34]

Traumatic pneumothorax

Case series (16)

DS

Decoction

Water

Total 7~18-pack

(1-pack/day)

7~18 days (2/day)

NA

1) Chest pain

2) Choking sensation in the chest

3) Dyspnea

4) CT examination of the right lung

1) Disappear

2–3) Breathe smoothly

4) Clear texture

Chen, M

[32]

Peptic ulcer

Case series (60)

DS

Decoction

Water and alcohol

28~56-pack

(1-pack/day)

4~8 weeks (NA)

NA

Effective number of people (%)b: significantly effective; effective; or non-effective

38 (63%); 18 (30%); 4 (7%)

Shao, Y. F. [33]

  1. aUsual care included oxygenation, endotracheal intubation, rib fixation, closed thoracic drainage, antibiotics, dexamethasone, ventilator, and treating other complications
  2. bEffectiveness was evaluated based on the main clinical symptoms, stomach ache, and ulcers
  3. ARDS acute respiratory distress syndrome; C control group; CRP C-reactive protein; CT computed tomography; DS Dangkwisoo-san; EQ-5D-5L European Quality of Life five-dimension-five-level scale; FAOS foot and ankle outcome scores; ICER incremental cost-effectiveness ratio; I intervention group; IL-6 interleukin-6; NA not available; NS not significant; PSA probabilistic sensitivity analysis; RCT randomized controlled trial; SIRS systemic inflammatory response syndrome; TNF tumor necrosis factor; VAS visual analog scale